Molecular Pharmacology & Drug Discovery
Our department houses strong expertise in structure-guided drug design, receptor biology, kinase signaling pathways, and rational therapeutic development.
By integrating structural biology, computational modeling, medicinal chemistry, and functional genomics, we translate molecular insight into therapeutic innovation.
Faculty in this area include:
- Dr. Hughes – Nuclear receptor structural dynamics (PPARγ, FXR, LXR)
- Dr. Holley – Computational neuroreceptor modeling
- Dr. Diaz – Ligand design and receptor pharmacology
- Dr. Pershouse – PTEN/PI3K/AKT/mTOR pathway targeting in cancer
- Dr. Riel – Structure-based immunomodulator design